Research Paper Volume 13, Issue 19 pp 22947—22962

A novel prognostic signature based on immune-related genes of diffuse large B-cell lymphoma

Validation of the prognostic signature. Kaplan-Meier plots of overall survival between high- and low-risk patients in the (A) internal validation cohort, (B) entire GSE31312 cohort, and (C) external validation cohort. Univariate Cox regression analyses in the (D) internal validation cohort, (E) entire GSE31312 cohort, and (F) external validation cohort. Multivariate Cox regression analysis in the (G) internal validation cohort, (H) entire GSE31312 cohort, and (I) external validation cohort.

Figure 4. Validation of the prognostic signature. Kaplan-Meier plots of overall survival between high- and low-risk patients in the (A) internal validation cohort, (B) entire GSE31312 cohort, and (C) external validation cohort. Univariate Cox regression analyses in the (D) internal validation cohort, (E) entire GSE31312 cohort, and (F) external validation cohort. Multivariate Cox regression analysis in the (G) internal validation cohort, (H) entire GSE31312 cohort, and (I) external validation cohort.